Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan J Darrow

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
Frontiers in Pharmacology|June 9, 2022
Generating Evidence from Expanded Access Use of Rare Disease Medicines: Challenges and RecommendationsTobias B Polak, David G J Cucchi, Joost van Rosmalen, et al.
JAMA Internal Medicine|October 3, 2022
Fulfillment of Postmarket Commitments and Requirements for New Drugs Approved by the FDA, 2013-2016Beatrice L Brown, Mayookha Mitra-Majumdar, Jonathan J Darrow, et al.
Clinical Pharmacology and Therapeutics|May 23, 2023
Physician Perspectives on the Food and Drug Administration's Decision to Grant Accelerated Approval to Aducanumab for Alzheimer's DiseaseSanket S Dhruva, Aaron S Kesselheim, Steven Woloshin, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|December 21, 2024
Physician-Patient Communication about Novel Drugs and High-Risk Medical DevicesSanket S Dhruva, Aaron S Kesselheim, Steven Woloshin, et al.
Health Affairs (Project Hope)|January 8, 2024
Physicians' Perspectives On FDA Regulation Of Drugs And Medical Devices: A National SurveySanket S Dhruva, Aaron S Kesselheim, Steven Woloshin, et al.
Journal of Health Politics, Policy and Law|July 22, 2022
Trends in the Quality of Evidence Supporting FDA Drug Approvals: Results from a Literature ReviewBeatrice L Brown, Mayookha Mitra-Majumdar, Krysten Joyce, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 25, 2018
Efficacy, Safety, and Regulatory Approval of Food and Drug Administration-Designated Breakthrough and Nonbreakthrough Cancer MedicinesThomas J Hwang, Jessica M Franklin, Christopher T Chen, et al.
Health Affairs (Project Hope)|May 8, 2018
Precision Medicines Have Faster Approvals Based On Fewer And Smaller Trials Than Other MedicinesLisette Pregelj, Thomas J Hwang, Damian C Hine, et al.
Health Affairs (Project Hope)|November 19, 2020
An Overview Of Vaccine Development, Approval, And Regulation, With Implications For COVID-19Aaron S Kesselheim, Jonathan J Darrow, Martin Kulldorff, et al.
JAMA Internal Medicine|November 28, 2022
Frequency of Approval and Marketing of Biosimilars With a Skinny Label and Associated Medicare SavingsAlexander C Egilman, Victor L Van de Wiele, Benjamin N Rome, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Frontiers in Pharmacology|June 9, 2022
Generating Evidence from Expanded Access Use of Rare Disease Medicines: Challenges and RecommendationsTobias B Polak, David G J Cucchi, Joost van Rosmalen, et al.
JAMA Internal Medicine|October 3, 2022
Fulfillment of Postmarket Commitments and Requirements for New Drugs Approved by the FDA, 2013-2016Beatrice L Brown, Mayookha Mitra-Majumdar, Jonathan J Darrow, et al.
Clinical Pharmacology and Therapeutics|May 23, 2023
Physician Perspectives on the Food and Drug Administration's Decision to Grant Accelerated Approval to Aducanumab for Alzheimer's DiseaseSanket S Dhruva, Aaron S Kesselheim, Steven Woloshin, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|December 21, 2024
Physician-Patient Communication about Novel Drugs and High-Risk Medical DevicesSanket S Dhruva, Aaron S Kesselheim, Steven Woloshin, et al.
Health Affairs (Project Hope)|January 8, 2024
Physicians' Perspectives On FDA Regulation Of Drugs And Medical Devices: A National SurveySanket S Dhruva, Aaron S Kesselheim, Steven Woloshin, et al.
Journal of Health Politics, Policy and Law|July 22, 2022
Trends in the Quality of Evidence Supporting FDA Drug Approvals: Results from a Literature ReviewBeatrice L Brown, Mayookha Mitra-Majumdar, Krysten Joyce, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 25, 2018
Efficacy, Safety, and Regulatory Approval of Food and Drug Administration-Designated Breakthrough and Nonbreakthrough Cancer MedicinesThomas J Hwang, Jessica M Franklin, Christopher T Chen, et al.
Health Affairs (Project Hope)|May 8, 2018
Precision Medicines Have Faster Approvals Based On Fewer And Smaller Trials Than Other MedicinesLisette Pregelj, Thomas J Hwang, Damian C Hine, et al.
Health Affairs (Project Hope)|November 19, 2020
An Overview Of Vaccine Development, Approval, And Regulation, With Implications For COVID-19Aaron S Kesselheim, Jonathan J Darrow, Martin Kulldorff, et al.
JAMA Internal Medicine|November 28, 2022
Frequency of Approval and Marketing of Biosimilars With a Skinny Label and Associated Medicare SavingsAlexander C Egilman, Victor L Van de Wiele, Benjamin N Rome, et al.
Pageof 9